Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology | Neurology
Disease Category: Schizophrenia and Schizoaffective Disorders
Location: United States, IL

Clinical Trial Details

Overview

Research Study Summary

A fifteen month, prospective, randomized, active-controlled, open-label, flexible dose study of paliperidone palmitate compared with oral antipsychotic treatment in delaying time to treatment failure in adults with schizophrenia who have been recently released from jail.

Purpose

This study will compare the effects (both good and bad) of paliperidone palmitate to those of several FDA approved oral antipsychotic medications used to treat schizophrenia.

The purpose of this study is to help understand if paliperidone palmitate or oral antipsychotic medication is better at preventing a worsening of your symptoms of schizophrenia which could cause an unfavorable outcome.

Please contact Alexian Brothers for more information on participation.

To Learn more
Phase

4

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Duration

15 Months

Facility Type

N/A

Contact

Alexian Brothers Hospital Network
1786 Moon Lake Boulevard, Suite 200
Hoffman Estates, IL 60169
Phone: 847-230-3599

View Map

Research Center Information: Alexian Brothers Hospital Network

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 176869

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.